Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells

Matthew King(AstraZeneca (United Kingdom)), Vikki Flemington(AstraZeneca (United Kingdom))
Oncogene
February 8, 2016
Cited by 87


Related Papers